About the 17th Annual Biotech in Europe Forum
|
The forum is recognised as the leading international stage for those interested in investing and partnering in the biotech and life science industry. This highly transactional event draws together an exciting cross-section of early-stage/pre-IPO, late-stage and public companies with leading investors, analysts, money managers and pharma licensing executives. Supported and designed by leading figures within Europe’s pharmaceutical and biotech industry, this event will once again be covered by our regular media partners. We expect over 650 delegates and over 100 presenting companies.
The 17th Annual BEF will be held for the fourth time in Basel to be close to the largest biopharma hub in Europe and the Congress Center provides meeting space capable of handling several thousand one-to-one meetings as well as significant exhibition space. The Programme will feature twelve plenary panels/workshops covering BD & Licensing in the main therapeutic areas. The Forum will provide a number of networking opportunities via our online one-to-one meeting system which allows you to pre-book meetings with all the attendees with dedicated meeting facilities. We expect more than 1500 meetings to take place throughout the 2 days. Plenary Sessions will include:
Therapeutic Panels will include:
Confirmed Keynotes Include:
Confirmed Speakers & Chairs include:
16th BEF Sponsors Included:
Presenting Opportunities:Presenting at the forum offers excellent opportunities to showcase your company to some of the leading global investors and corporates. It will offer you the opportunity to communicate your projected capital raising plans or simply help you in finding the right partner for your business. Presenting companies from Europe and the US will benefit from specially designed panels and keynote addresses from leading industry figures as well as access to some of the leading analysts and investors from Europe and beyond. This year, we aim to expand the audience and provide once again, opportunities for executive-level networking, deal-making and strategic partnering. The forum is recognised as the leading international stage for those interested in investing in the biotech and life science industry and is highly transactional, drawing together an exciting cross-section of early-stage/pre-IPO, late-stage and public companies with leading investors, analysts, money managers and pharmas. Supported and designed by leading figures within Europe’s bio industry, this event will once again be covered by our regular media partners.
Presenters at the 16th BEF included:
Exhibiting Opportunities:Make connections, engage in conversation, and exchange knowledge with key decision-makers eager to learn how your company can help them meet their goals and achieve their mission. Exhibiting at 17th Annual Biotech in Europe Forum is an effective way to gain leads, introduce new products and services, expand sales, and build relationships.
Exhibitors at the 16th BEF included:
Sachs Associates has developed an extensive knowledge of the key individuals operating within the European and global biotech industry. This together with a growing reputation for excellence puts Sachs Associates at the forefront of the industry and provides a powerful tool by which to increase the position of your company in this market.
Raise your company’s profile directly with your potential clients. All of our sponsorship packages are tailor made to each client, allowing your organisation to gain the most out of attending our industry driven events. To learn more about presenting, exhibition or sponsorship opportunities, please contact: Silvia Kar on + 44 (0)203 463 4890 or by email: Silvia. |
Host Sponsor:
Reception Sponsor:
Silver Sponsor:
Supporters:
Pharma Licensing Groups
Attending in 2017: 
Financial, Advisory, Investors
Attending in 2017: Abingworth LLP ACXIT Capital Partners Adveq Management Aglaia BioMedical Ventures Apex Healthcare Consulting Ltd. Aravis SA Asklepios SAS ATGN Consulting Atlantic Labs AWA BaseLaunch Bavarian Capital Management Bellevue Asset Management AG Belsize Asset Management GmbH Bergmann zur Hausen & Cie. GmbH Bio Capital Impact Fund Bio Medi Gene Ventures BioBac BioValley Basel Business Angels Club BioMedPartners AG BioStart Consulting GmbH Biotech Alliances International, Inc. Bird & Bird LLP Boehringer Ingelheim Venture Fund Bootstrap Europe Bpifrance Breslin AG Capital Cell Capricorn One Capricorn Venture Partners NV CenseoVentures LLC Clarena AG Colpman Consulting Ltd. Creathor Ventures Cukierman & Co. Life Sciences Dievini Dybly AG E. Gutzwiller & Cie, Banquiers Economic and Trade Department, Embassy of Israel in Switzerland Edison Group Edmond de Rothschild Investment Partners EIT Health e.V. Ekins Guinness LLP Eminent Venture Capital Corporation / TaiAn Technologies Euronext European Investment Bank EVA - the Basel life sciences start-up agency FastVentures B.V. Forbion Capital Partners View Full List >>> |
